ProSomnus Inc. (OSAP)
OTCMKTS: OSAP · Delayed Price · USD
0.140
0.00 (0.00%)
Apr 25, 2024, 12:00 AM EDT - Market open
Company Description
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea.
The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force.
ProSomnus, Inc. is headquartered in Pleasanton, California.
ProSomnus Inc.
| Country | Canada |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 136 |
Contact Details
Address: 5675 Gibraltar Dr Pleasanton, California 94588 United States | |
| Phone | 844-537-5337 |
Stock Details
| Ticker Symbol | OSAP |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| CIK Code | 0001934064 |
| Employer ID | 88-2978216 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Leonard Liptak | Co-Founder, Chief Executive Officer and Director |
| Sung Kim | Co-Founder and Chief Technology Officer |
| Laing F. Rikkers | Co-founder and Executive Chairman |
| Brian B. Dow | Chief Financial Officer and Corporate Secretary |
| Dr. John E. Remmers M.D. | Chief Scientist |
| Heather Whalen | Vice President of Global Marketing Services |
| Dr. Shouresh Charkhandeh D.D.S. | Global Scientific Committee Chair |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 25, 2024 | 25-NSE | Filing |
| Apr 19, 2024 | 8-K | Current Report |
| Apr 18, 2024 | 8-K | Current Report |
| Mar 27, 2024 | 10-K | Annual Report |
| Mar 26, 2024 | 8-K | Current Report |
| Mar 22, 2024 | 8-K | Current Report |
| Feb 16, 2024 | 8-K | Current Report |
| Feb 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Feb 13, 2024 | EFFECT | Notice of Effectiveness |
| Feb 13, 2024 | EFFECT | Notice of Effectiveness |